Vav modulation of the Ras/MEK/ERK signaling pathway plays a role in NFAT activation and CD69 up-regulation

European Journal of Immunology

Volumn 30, Issue 6, 2000, Pages 1587-1596

  Villalba, Martin ^a,b   Hernandez, Jerry ^a,b   Deckert, Marcel ^a,b   Tanaka, Yoshihiko ^a,b   Altman, Amnon ^a,b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b INSERM   (France)

Author keywords

CD69; NFAT; Ras ERK; T cell; Vav

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BINDING PROTEIN; CALCINEURIN; CD69 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MUTANT PROTEIN; NUCLEAR FACTOR; RAS PROTEIN; UNCLASSIFIED DRUG; VAV PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DOMINANT GENE; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; HUMANS; JURKAT CELLS; MAP KINASE KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MOLECULAR MIMICRY; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; RAS PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0034086261     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T     Document Type: Article

References (63)

1. Romero, F. and Fischer, S., Structure and function of Vav. Cell. Signal. 1996. 8: 545-553.
2. Collins, T., Deckert, M. and Altman, A., Views on Vav. Immunol. Today 1997.18:221-225.
3. Gérions, R. A. and Zheng, Y., The Dbl family of oncogenes. Curr. Opin. Cell. Biol. 1996. 8:216-222.
4. Whitehead, I. P., Campbell, S., Rossman, K. L. and Der, C. J., Dbl family proteins. Biochim. Biophys. Acta 1997.1332: F1-F23.
5. Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S. and Busteolo, X. R., Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 1997.385:169-172.
6. Ran, J., Luby Phelps, K., Das, B., Shu, X., Xia, Y., Mosteller, R. D., Krishna, U. M., Falck, J. R., White, M. A. and Broek, D., Lck regulates Vav activation of members of the Rho family of GTPases. Mol. Cell. Biol. 17:1346-1353.
7. Khosravi-Far, R., Chrzanowska-Wodnicka, M., Solski, P. A., Eva, A., Burridge, K. and Der, C. J., Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol. Cell. Biol. 1994.14:6848-6857.
8. Olson, M. F., Pasteris, N. G., Goski, J. L. and Hall, A., Fasciogenital dysplasia protein (FGD1) and Vav, two related protein required for normal embryonic development, are upstream regulators of Tho GTPases. Curr. Biol. 1996. 6:1628-1633.
9. Ma, A. D., Metjian, A., Bagrodia, S., Taylor, S. and Abrams, C. S., Cytoskeletal reorganiztation by G protein-coupled receptors in dependent on phosphoinositide 3-kinase g, a Rac guanosine exchange factor, and Rac. Mol. Cell. Biol. 1998.18:4744-4751.
10. + thymocytes. Nature 1995. 374: 474-477.
11. Tarakhovsky, A., Turner, M., Schaal, S., Mee, P. J., Duddy, L. P., Rajewsky, K. and Tybulewicz, L. J., Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995.374: 467-470.
12. Zhang, R., Alt, F. W., Davidson, L., Orkin, S. H. and Swat, W., Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 1995. 374: 470-473.
13. Turner, M., Mee, P. J., Walters, A. E., Quinn, M. E., Mellor, A. L., Zamoyska, R. and Tybulewicz, V. L. J., A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 1997. 7:451-460.
14. Fischer, K. D., Kong, Y. Y., Nishina, H., Tedford, K., Marengère, L. E., Kozieradzki, I., Sasaki, T., Starr, M., Chan, G., Gardener, S., Nghiem, M. P., Bouchard, D., Barbacid, M., Bernstein, A. and Penninger, J. M., Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 1998. 8: 554-562.
15. Holsinger, L. J., Graef, I. A., Swat, W., Chi, T., Bautista, D. M., Davidson, L., Lewis, R. S., Alt, F. W. and Crabtree, G. R., Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 1998.8:563-572.
16. vav activity. Mol. Cell. Biol. 1995. 15: 4337-4346.
17. Holsinger, L. J., Spencer, D. M., Austin, D. J., Schreiber, S. L. and Crabtree, G. R., Signal transduction in T lymphocytes using a conditional allele of Sos. Proc. Natl. Acad. Sei. USA 1995. 92: 9810-9814.
18. Deckert, M., Tartare Deckert, S., Couture, C., Mustelin, T. and Altman, A., Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 1996. 5: 591-604.
19. Rao, A., Luo, C. and Hogan, P. G., Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 1997. 15: 707-747.
20. Crabtree, G. R., Genetic signals and specific outcomes: signaling through Ca2', calcineurin and NF-AT. Cell 1999.96:611-614.
21. Masuda, E. S., Imamura, R., Amasaki, Y., Arai, K. and Arai, N., Signalling into the T-cell nucleus: NFAT regulation. Cell. Signal. 1998. 10:599-611.
22. Bubeck Wardenburg, J., Pappu, R., Bu, J. Y., Mayer, B., Chernoff, J., Straus, D. and Chan, A. C., Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76. Immunity 1998. 9:607-616.
23. Musci, M. A., Motto, D. G., ROSS, S. E., Fang, N. and Koretzky, G. A., Three domains of SLP-76 are required for its optimal function in a T cell line. J. Immunol. 1997.159:1639-1647.
24. Raab, M., da Silva, A. J., Findell, P. R. and Rudd, C. E., Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR Z/CD3 induction of interleukin-2. Immunity 1997. 6:155-164.
25. Tuosto, L., Michel, F. and Acuto, O., p95v associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med. 1996.184:1161-1166.
26. Wu, J., Motto, D. G., Koretzky, G. A. and Weiss, A., Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 1996. 4: 593-602.
27. Katzav, S., Sutherland, M., Packham, G., Yi, T. and Weiss, A., The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. J. Biol. Chem. 1994. 269: 32579-32585.
28. Katzav, S., Cleveland, J. L., Heslop, H. E. and Pulido, D., Loss of the amino-terminal helix-loop-helix domain of the vav protooncogene its transforming potential. Mol. Cell. Biol. 1991. 11: 1912-1920.
29. Crespo, P., Bustelo, X. R., Aaronson, D. S., Coso, O. A., Lopez, B. M., Barbacid, M. and Gutkind, J. S., Rac-1 dependent stimu-lation of the JNK/SAPK signaling pathway by Vav. Oncogene 1996.13:455-460.
30. Teramoto, H., Salem, P., Robbins, K. C., Bustelo, X. R. and Gutkind, J. S., Tyrosine phosphorylation of the vav protooncogene product links FctRI to the Rac1-JNK pathway. J. Biol. Chem. 1997. 272:10751-10755.
31. Gulbins, E., Coggeshall, K. M., Langtet, C., Baier, G., Bonnefoy-Berard, N., Burn, P., Wittinghofer, A., Katzav, S. and Altman, A., Specific activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol. Cell. Biol. 1994.14:906-913.
32. Miranti, C. K., Leng, L., Maschberger, P., Brugge, J. S. and Shattil, S. J., Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr. Biol. 1998. 8: 1289-1299.
33. Costello, P. S., Walters, A. E., Mee, P. J., Turner, M., Reynolds, L. F., Prisco, A., Sarner, N., Zamoyska, R. and Tybulewicz, V. L. J., The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-KB pathways. Proc. Natl. Acad. Sei. USA 1999. 96: 3035-3040.
34. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. and Saltiel, A. R., PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 1995. 270: 27489-27494.
35. Izquierdo, M., Leevers, S. J., Marshall, C. J. and Cantrell, D., p21ras couples the T cell antigen receptor to extracellular signalregulated kinase in 2 in T lymphocytes. J. Exp. Med. 1993. 178: 1199-1208.
36. Clipstone, N. A. and Crabtree, G. R., Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992.357:695-697.
37. ras and calcineurin synergize to regulate the nuclear factor of activated T cells. J. Exp. Med. 1993.178:1517-1522.
38. Baldari, C. T., Heguy, A. and Telford, J. L, ras protein activity is essential for T-cell antigen receptor signal transduction. J. Biol. Chem. 1993. 268: 2693-2698.
39. Woodrow, M. A., Rayter, S., Downward, J. and Cantrell, D. A., p21m function is important for T cell antigen receptor and protein kinase C regulation of nuclear of activated T cells. J. Immunol. 1993.150:3853-3861.
40. Villalba, M., Coudronniere, N., Deckert, M., Teixeiro, E., Mas, P. and Altman, A., Functional interactions between Vav and PKCq are required for TCR-induced T cell activation. Immunity 2000. 12:151-160.
41. ras upon T-cell activation. Nature 1990.346:719-723.
42. D'Ambrosio, D., Cantrell, D. A., Frati, L., Santoni, A. and Testi, R., Involvement of p21ras in T cell CD69 expression. Eur. J. Immunol. 1994.24:616-620.
43. ras through tyrosine phosphorylation of the protooncogene prouct Vav. Proc. Natl. Acad. Sei. USA 1996. 93: 8431-8436.
44. Song, J. S., Gomez, J., Stancato, L. F. and Rivera, J., Association of a p95 Vav-containing signaling complex with the FceRI chain in the RBL-2H3 mast cell line. Evidence for a constitutive in vivo association of Vav with Grb2, Raf-1, and ERK2 in an active complex. J. Biol. Chem. 1996. 271:26962-26970.
45. Lee, I. S., Liu, Y., Narazaki, M., Hibi, M., Kishimoto, T. and Taga, T., Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6. FEBS Lett. 1997. 401:133-137.
46. Koretzky, G. A., The role of Grb2-associated proteins in T-cell activation. Immunol. Today 1997.18: 401-406.
47. Jackman, J. K., Motto, D. G., Sun, Q., Tanemoto, M., Turck, C. W., Peltz, G. A., Koretzky, G. A. and Findell, P. R., Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J. Biol. Chem. 1995. 270: 7029-7033.
48. Graziadei, L., Riabowol, K. and Bar-Sagi, D., Co-capping of ras proteins with surface immunoglobulins in B lymphocytes. Nature 1990.347:396-400.
49. O'Rourke, L M., Tooze, R., Turner, M., Sandoval, D. M., Carter, R. H., Tybulewicz, V. L. and Fearon, D. T., CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 1998. 8: 635-645.
50. Yablonski, D., Kane, L. P., Quian, D. and Weiss, A., A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK. EMBOJ. 1998. 17: 5647-5657.
51. Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S. and Lim, L., A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994. 36: 40-46.
52. Bagrodia, S., Taylor, S. J., Creasy, C. L, Chernoff, J. and Cerione, R. A., Identification of a mouse p21Cdc42/Rac activated kinase. J. B/oJ. Chem. 1995. 270: 22731-22737.
53. Martin, G. A., Bollag, G., McCormick, F. and Abo, A., A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J. 1995. 14: 1970-1978.
54. Manser, E., Huang, H.-Y., Loo, T.-H., Chen, X.-Q., Dong, J.-M., Leung, T. and Lim, L., Expression of constitutively active a-PAK reveals effects of the kinase on actin and focal complexes. Mol. Cell. Biol. 1997.17: 1129-1143.
55. Sells, M. A., Knaus, U. G., Bagrodia, S., Ambrose, D. M., Bokoch, G. M. and Chernoff, J., Human p21-activated kinase (Pak1) regulated actin organization in mammalian cells. Curr. Biol. 1997.7:202-210.
56. Frost, J. A., Xu, S., Hutchison, M. R., Marcus, S. and Cobb, M. H., Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Mol. Cell. Biol. 1996.16:3707-3713.
57. Lu, W., Katz, S., Gupta, R. and Mayer, B. J., Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nek. Curr. Biol. 1997. 7:85-94.
58. Khosravi Far, R. S. P., Clark, G. J., Kinch, M. S. and Der, C. J., Activation of Rac, RhoA and mitogen activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 1995. 15: 6443-6453.
59. Qiu, R. G., Chen, J., Kirn, D., McCormick, F. and Symons, M., An essential role for Rac in Ras transformation. Nature 1995.374: 457-459.
60. Genot, E., Cleverley, S., Henning, S. and Cantrell, D., Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J. 1996. 15: 3923-3933.
61. Werlen, G., Jacinto, E., Xia, Y. and Karin, M., Calcineurin preferentially synergizes with PKC-q to activate JNK and IL-2 promoter in T lymphocytes. EMBOJ. 1998.17: 3101-3111.
62. Liu, Y.-C., Elly, C., Langdon, W. Y. and Altman, A., Rasdependent, Ca2'-stimulated activation of NFAT by a constitutively active Cbl mutant in T cells. J. Biol. Chem. 1997. 272:168-173.
63. Villalba, M., Kasibhatla, S., Genestier, L, Mahboubi, A., Green, D. R. and Altman, A., PKCq is a necessary component, and cooperates with calcineurin, to induce FasL expression during activation-induced T cell death. J. Immunol. 1999. 163: 5813-5819.